Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
287
287 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- JDQ443OpnurasibPhase 23 trials
Novartis · Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation, Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation
- MCLA-129Phase 23 trials
Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, Solid Tumor, Head and Neck Cancer
- PD-L1 t-haNKPhase 23 trials
ImmunityBio, Inc. · Pancreatic Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer
- REGN10597PD-1-IL2Ra-IL2 immunotherapyPhase 23 trials
Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
- REGN7075marlotamigPhase 23 trials
Regeneron · Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer
- RMC-6291ElironrasibPhase 23 trials
Revolution Medicines, Inc. · Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer
- RMC-9805Phase 23 trials
Revolution Medicines, Inc. · PDAC, Colorectal Cancer, CRC
- roginolisibIOA-244Phase 23 trials
iOnctura · Myelofibrosis (MF), Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Advanced Non Squamous NSCLC
- SKB118Phase 23 trials
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Non-Squamous Non-Small Cell Lung Cancer, Advanced Solid Tumors, NSCLC
- SSGJ-706Phase 23 trials
Shenyang Sunshine Pharmaceutical Co., LTD. · Non Small Cell Lung Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC)
- SYS6090Phase 23 trials
CSPC Megalith Biopharmaceutical Co.,Ltd. · HCC - Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Small Cell Lung Cancer
- Tmod CAR T-cell TherapyA2B530, A2B694Phase 23 trials
A2 Biotherapeutics Inc. · Solid Tumor, Adult, Colorectal Cancer, Colorectal Adenocarcinoma
- valemetostat tosylateDS-3201bPhase 23 trials
Daiichi Sankyo · Non-small Cell Lung Cancer, Lung Cancer, Relapsed/Refractory Peripheral T-Cell Lymphoma
- WSD0922-FUWSD0922Phase 23 trials
Wayshine Biopharm, Inc. · Non Small Cell Lung Cancer (NSCLC), EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer
- ABSK061Phase 22 trials
Abbisko Therapeutics Co, Ltd · HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer
- AK129Phase 22 trials
Akeso · Non-small Cell Lung Cancer Stage IIIB/IV, Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Adenocarcinoma
- AK138D1Phase 22 trials
Akeso · Non-Small Cell Lung Cancer, Breast Cancer
- ALK201Phase 22 trials
Shanghai Allink Biotherapeutics Co., Ltd. · NSCLC (Advanced Non-small Cell Lung Cancer), Advanced Cancer, Advanced Solid Tumors
- Ametinib MesylatePhase 22 trials
Shanghai Hengrui Pharmaceutical Co., Ltd. · Advanced Solid Tumors, Non-small Cell Lung Cancer (NSCLC)
- Autologous Tumor Infiltrating LymphocytesGC101 TILPhase 22 trials
Shanghai Juncell Therapeutics · Non Small Cell Lung Cancer, Melanoma
- AZD0171MSC-1Phase 22 trials
AstraZeneca · Non-small Cell Lung Cancer, Locally Advanced or Metastatic Solid Tumours
- B1962Phase 22 trials
Tasly Biopharmaceuticals Co., Ltd. · Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers
- BNT326Phase 22 trials
BioNTech SE · Advanced Solid Tumor, Non-small Cell Lung Cancer
- CAB-AXL-ADCBA3011Phase 22 trials
BioAtla, Inc. · Non-Small-Cell Lung Cancer, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma
- Carboplatin AUC-5Phase 22 trials
Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer
- Dositinib mesylatePhase 22 trials
Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer
- DS-3939aPhase 22 trials
Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
- DSP107Phase 22 trials
Kahr Bio Australia Pty Ltd · Colorectal Cancer, Advanced Solid Tumor, Non Small Cell Lung Cancer
- DZD6008Phase 22 trials
Dizal Pharmaceuticals · Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer
- FMC-376Phase 22 trials
Frontier Medicines Corporation · Advanced Solid Tumors With KRAS G12C Mutations, Solid Tumor, Adult, Unresectable Solid Tumor
- ImzokitugBMS-986340Phase 22 trials
Bristol Myers Squibb · Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC), Cervical Cancer
- KB707Phase 22 trials
Krystal Biotech, Inc. · Cancer, Melanoma Stage III, Melanoma Stage IV
- KCBT-1083BEBT-109Phase 22 trials
BeBetter Med Inc · Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation
- KN046Recombinant Humanized PD-L1, CTLA-4 Bispecific Single Domain Antibody Fc Fusion ProteinPhase 22 trials
InxMed (Shanghai) Co., Ltd. · Pancreatic Cancer, Advanced Non-small Cell Lung Cancer
- LM103 TILsPhase 22 trials
Suzhou BlueHorse Therapeutics Co., Ltd. · Advanced Melanoma, Non-Small Cell Lung Cancer
- LS301-ITPhase 22 trials
Integro Theranostics · Non Small Cell Lung Cancer (NSCLC), Breast Cancer, DCIS
- M1774TuvusertibPhase 22 trials
EMD Serono Research & Development Institute, Inc. · Non-Small Cell Lung Cancer, Ovarian Cancer
- NelistotugGSK6097608Phase 22 trials
GSK · Lung Cancer, Non-Small Cell, Neoplasms, Head and Neck
- NelmastobartPhase 22 trials
STCube, Inc. · Metastatic Colorectal Cancer (CRC), Recurrent Colorectal Cancer, Non Small Cell Lung Cancer
- ODM-212Phase 22 trials
Orion Corporation, Orion Pharma · Solid Tumours, Mesothelioma, Pancreatic Cancer
- PD-L1 monoclonal antibodyPhase 22 trials
Suzhou BlueHorse Therapeutics Co., Ltd. · Non-Small Cell Lung Cancer, Advanced Malignant Solid Tumor
- quaratusugene ozeplasmidREQORSAPhase 22 trials
Genprex, Inc. · Carcinoma, Non-Small Cell Lung, Small Cell Lung Cancer Extensive Stage
- QuavonlimabMK-1308Phase 22 trials
Merck & Co. · Melanoma, Advanced Non-Small Cell Lung Cancer
- RAPA-201 Rapamycin Resistant T CellsRAPA-201 cellsPhase 22 trials
Rapa Therapeutics LLC · Malignant Melanoma, Malignant Melanoma With Metastasis, Malignant Melanoma Stage IIIc
- RC108Phase 22 trials
RemeGen Co., Ltd. · Non-Small Cell Lung Cancer, Digestive Cancer
- RDEABSK141-Recommended Expansion, S095018 RecommendedPhase 22 trials
Abbisko Therapeutics Co, Ltd · Solid Tumors, Adult, Non-small Cell Lung Cancer (NSCLC)
- S095029Phase 22 trials
Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC), MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer
- silevertinibBDTX-1535Phase 22 trials
Black Diamond Therapeutics, Inc. · Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM
- SPGL008Phase 22 trials
Shenyang Sunshine Pharmaceutical Co., LTD. · NMIBC, Non Small Cell Lung Cancer
- Sutetinib MaleatePhase 22 trials
Teligene US · Non-small Cell Lung Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.